Abstract
Objectives/Hypothesis:
Advances in bone repair have focused on the minimally‐invasive delivery of tissue‐engineered bone (TEB). A promising injectable biopolymer of chitosan and inorganic phosphates was seeded with mesenchymal stem cells (MSCs) and a bone growth factor (BMP‐2), and evaluated in a rat calvarial critical size defect (CSD). Green fluorescent protein (GFP)‐labeled MSCs are used to evaluate patterns of cell viability and proliferation.
Study Design:
Prospective, controlled trial in an animal model.
Methods:
In 30 male rats, 8‐mm calvarial CSDs were created, and divided into five groups of six animals each. In the experimental groups, the defects were injected with either chitosan gel, gel loaded with MSCs (0.3 × 10^6^ cells/defect), gel loaded with BMP‐2 (2 μg/defect), or gel loaded with both MSC and BMP‐2. In the control group, the defect was left untreated. At 4 weeks, in vivo microcomputed tomography (micro‐CT) analysis was performed. At 8 weeks, calvarial specimens were examined by micro‐CT, histology, and immunohistochemistry.
Results:
New areas of bone growth were seen in the defects of all treated animals. Micro‐CT analysis revealed a significant (P < .001) time‐dependent increase in the regeneration of bone volume and bone area in defects treated with gel/MSC/BMP‐2 as compared to all other groups. Histological analysis confirmed this difference. GFP–labeled TEB was detected within the areas of new bone, indicating cell viability and contribution to new bone growth by the injected MSC.
Conclusions:
This study demonstrates that an injectable form of TEB using a chitosan gel, MSC, and BMP‐2 can enhance bone formation in a rat calvarial CSD. Laryngoscope, 2010